Revolax™ Sub-q
REVOLAX™ Sub-Q with Lidocaine has the thickest properties within the product line. With its advanced ability to mould, maintain structure, and longevity, REVOLAX™ Sub-Q with Lidocaine is recommended for the treatment of deep-sized to extremely severe wrinkles, including nasolabial folds. This dermal filler also works best for cheek, chin, nose and jawline augmentation that require a thicker substance to fill.
Key Features
• REVOLAX Sub-Q is the thickest dermal filler in the REVOLAX range
• Lasts between 12-18 months.
• Biodegradable, non-animal-based, cross-linked dermal filler for subcutaneous implantation
• A Class III, CE-marked medical device, legal to use in the Serbia as it meets all stringent safety tests.
• Lasts between 12-18 months.
• Biodegradable, non-animal-based, cross-linked dermal filler for subcutaneous implantation
• A Class III, CE-marked medical device, legal to use in the Serbia as it meets all stringent safety tests.
Treatments Area
• Deep-sized to extremely severe wrinkles
• Nasolabial folds
• Cheek
• Chin
• Nose
• Jawline augmentation
• Nasolabial folds
• Cheek
• Chin
• Nose
• Jawline augmentation
Composition
• Hyaluronic acid concentration 24mg/ml
• Lidocaine HCl 0.3%
• Volume 1.1ml
• Duration 12-18 Months
• 280 MPa
• Lidocaine HCl 0.3%
• Volume 1.1ml
• Duration 12-18 Months
• 280 MPa
Warning
Who Should Not Use REVOLAX™ Sub-q with Lidocaine?:
• Women who are pregnant or breastfeeding.
• People under the age of 18.
• Patients who are known to demonstrate hypersensitivity to hyaluronic acid.
• Patients who are known to demonstrate hypersensitivity to lidocaine.
• Patients who tend to develop hypertrophic scarring.
• Immediately before or post laser therapy, chemical peeling or dermabrasion.
• Areas presenting cutaneous inflammation or signs of infection.
• Women who are pregnant or breastfeeding.
• People under the age of 18.
• Patients who are known to demonstrate hypersensitivity to hyaluronic acid.
• Patients who are known to demonstrate hypersensitivity to lidocaine.
• Patients who tend to develop hypertrophic scarring.
• Immediately before or post laser therapy, chemical peeling or dermabrasion.
• Areas presenting cutaneous inflammation or signs of infection.
